Endonovo Therapeutics Announces Issuance of U.S. Patent Covering Apparatus and Method for Electromagnetic Treatment of Neurological Injury or Condition Caused by a Stroke
07. Januar 2020 08:30 ET
|
Endonovo Therapeutics, Inc.
Issuance of U.S. Patent No. 15217855 Further Bolsters Endonovo’s Intellectual Patent Portfolio Los Angeles, CA, Jan. 07, 2020 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDVD /...
Endonovo Therapeutics Provides SofPulse® To All NFL Teams [Updated]
23. Dezember 2019 09:48 ET
|
Endonovo Therapeutics, Inc.
Los Angeles, CA, Dec. 23, 2019 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDVD) ("Endonovo" or the "Company"), announced today the delivery of SofPulse® evaluation units to all...
Endonovo Therapeutics Announces Effective Date of Previously Announced Reverse Split of Common Stock
19. Dezember 2019 18:24 ET
|
Endonovo Therapeutics, Inc.
Los Angeles, CA, Dec. 19, 2019 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company"), announced today that its previously announced 1-for-1,000 reverse split of...